• DNDi - Best Science for the Most Neglected 20 Years
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • COVID-19
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • HELP Helminth Elimination Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi Southern Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
DNDi - Best Science for the Most Neglected 20 Years
  • DNDi - Best Science for the Most Neglected 20 Years
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • COVID-19
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • HELP Helminth Elimination Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi Southern Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > News Translations

博鳌亚洲论坛全球健康论坛第二届大会将2021年6月1日-4日在中国山东省青岛市举行,今年的大会主题为“人人得享健康“。

Home > News Translations

博鳌亚洲论坛全球健康论坛第二届大会将2021年6月1日-4日在中国山东省青岛市举行,今年的大会主题为“人人得享健康“。

Boao Forum for Asia 2021
1 Jun 2021
Share on twitter
Share on facebook
Share on linkedin
Share on email
Share on print
  • 中文
    • English
    • 中文

此分论坛重点介绍在于亚洲低收入和中等收入国家(LMICs)对抗丙型肝炎(HCV)所采取的各种策略 – 达到消除丙型肝炎(HCV)对亚洲的威胁:从高额治疗到可及性治疗方案。陈仲丹博士(世界卫生组织驻华代表处,艾滋病/病毒性肝炎/性传播感染/结核病技术官员)将出任本次分论坛主持人。

博鳌亚洲论坛第二届全球健康论坛大会以“ 健康无处不在—可持续发展的2030时代 ”为主题,“人人得享健康”为目标;聚集各地的政要专家、非营利组织、学术人士和私营机构,通过一系列地线上和线下的会议和活动,讨论全民健康覆盖相关话题,旨在促进全球公共卫生领域之间的合作。  

全球健康论坛将重点关注在三个不同领域,分别是:“实现全民健康”、“创新促进健康”和“健康融入所有政策”。为期四天的大会将有超过1500人出席到现场以及一亿名线上(虚拟)观众一同参与。大会活动由1个开幕式大会、2场全体大会、33个分论坛和15场主要活动组构而成。

被忽略疾病药物研发倡议组织(DNDi)已获邀出席在2021年6月3日(马来西亚/北京时间中午1:30pm-3:00pm,日内瓦时间早上7:30am-9:00am),所举行的“消除丙型肝炎对亚洲的威胁:从高额治疗到可及性治疗方案”分论坛为主讲单位。这一次的会议将会把重点讨论放在亚洲低收入和中等收入国家(LMICs),在为了达成“世界卫生组织(WHO)2030年消除病毒肝炎为目标”所采取的一切举措与方案。

今年亦是被忽略疾病药物研发倡议组织 (DNDi) 主席,Dr. Marie-Paule Kieny 玛丽保尔基尼医生首次应邀在博鳌亚洲论坛丙型肝炎主题分论坛上发表演讲。玛丽保尔基尼医生将在论坛上介绍与说明DNDi的合作与研发模式,以及强调DNDi以帮助被忽视疾病患者并提供给他们公平以及可持续性治疗为目标。此外,她也会在论坛上提及南半球国家新血加入成为强大领导能力的需要;以便能弥补并拉近更多全球被忽视疾病病患的基本卫生差距鸿沟以及能在相关领域拥有更优秀的创新与研发。

在全球健康论坛上,(DNDi) 主席玛丽保尔基尼医生将会与5位嘉宾一同讨论相关话题,他们分别是:马来西亚卫生部卫生总监,Noor Hisham Abdullah 诺希山医生;第三世界网络法律顾问,朱贞艳小姐;无国界医生柬埔寨项目总管,米凯尔 尼帕先生;北京协和医学院药物政策副教授,孙静博士和歌礼制药有限公司创始人,董事会主席兼首席执行官,吴劲梓博士。

受邀嘉宾们将会讨论有关丙型肝炎(HCV)治疗中的所面对的重要议题,并从中介绍与解说各种有助提高丙肝药物可及性的工具与策略。值得一提的是,这些工具和策略对于在帮助中国消灭丙型肝炎的路上,有着举重若轻的作用。分论坛讨论所涉及的主要课题包括:

  • 处理并关注丙型肝炎治疗中的知识产权课题:以便让亚洲低收入和中等收入国家(LMICs)在可及性治疗上得到更大的助力,从而让治疗普及化。
  • 丙型肝炎公共卫生领导心得之谈:Noor Hisham Abdullah 诺希山医生将会讨论并分享关于马来西亚丙型肝炎的治疗之路—其中包括药物普及化、可负担性治疗、病毒检测和分管策略相关经验。
  • 中国丙型肝炎治疗提供与资金议题:面对并解决病患所面对的药物可及性障碍。
  • 扩大丙型肝炎公共卫生处理规模:更好的诊断与治疗策略方案得以促使丙型肝炎公共卫生问题处理范围加以扩大 –柬埔寨,金边Preah Kossamak医院的治疗方案个案研究。
  • 丙型肝炎的创新研发,药物生产,以及扩大并改善公共卫生规模。

更多资讯,可以点击此链接:http://www.ghfbfa.cn

Photo credit: Xinhua/Yang Guanyu

Hepatitis C Asia China

Read, watch, share

Loading...
Davide Paparo and Ian Hausler with their thermotherapy device "CLARA"
Stories
16 Mar 2023

Cutaneous leishmaniasis: Swiss students develop innovative thermotherapy device for safer treatment of ‘flesh-eating parasite’

Stories
8 Mar 2023

Highlighting gender-based treatment gaps on International Women’s Day: Mary Alamak’s story

DNDi-GARDP Southern Africa director, Carol Ruffell (left), presents the December 2022 edition of HIV Nursing Matters and the 2022 paediatric ARV dosing chart to Bénédicte Schutz, Monaco’s Director of International Cooperation (centre), and Yordanos Pasquier, Monaco’s Deputy Director of International Cooperation (right).
News
3 Mar 2023

Working together to ensure optimal treatment for children living with HIV in South Africa

Nurse with patient
Press releases
1 Mar 2023

Fiocruz and DNDi sign strategic alliance agreement

Statements
28 Feb 2023

DNDi’s submission to the Technical Assessment component of the first Global Stocktake

Statements
22 Feb 2023

DNDi comments on the zero draft of the WHO CA+ for consideration of the Intergovernmental Negotiating Body at INB4 & 5

Hat Platform Newsletter N°22 screenshot
Publications
22 Feb 2023

HAT Platform Newsletter No. 22

Lab activities
News
20 Feb 2023

First in-person Dengue Alliance meeting brings together experts from dengue-endemic countries to develop treatments for a growing viral threat

VIEW ALL

Help neglected patients

To date, we have delivered twelve new treatments, saving millions of lives.

Our goal is to deliver 25 new treatments in our first 25 years. You can help us get there. 

GIVE NOW
DNDi - Best Science for the Most Neglected 20 Years
Facebook-f
Twitter
Instagram
Linkedin-in
Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License   
We use cookies to track our audience and improve our content. By clicking 'Accept All', you are agreeing to our use of cookies. Click on 'Customize' to accept only some cookies.
Customize
REJECT ACCEPT ALL
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-advertisement1 yearSet by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
CookieLawInfoConsent1 yearRecords the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie.
PHPSESSIDsessionThis cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
CookieDurationDescription
elementorneverThis cookie is used by the website's WordPress theme. It allows the website owner to implement or change the website's content in real-time.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
CookieDurationDescription
_ga2 yearsThe _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
_ga_16Q5RH3XRG2 yearsThis cookie is installed by Google Analytics.
_gat_UA-10302561-11 minuteA variation of the _gat cookie set by Google Analytics and Google Tag Manager to allow website owners to track visitor behaviour and measure site performance. The pattern element in the name contains the unique identity number of the account or website it relates to.
_gid1 dayInstalled by Google Analytics, _gid cookie stores information on how visitors use a website, while also creating an analytics report of the website's performance. Some of the data that are collected include the number of visitors, their source, and the pages they visit anonymously.
_hjAbsoluteSessionInProgress30 minutesHotjar sets this cookie to detect the first pageview session of a user. This is a True/False flag set by the cookie.
_hjFirstSeen30 minutesHotjar sets this cookie to identify a new user’s first session. It stores a true/false value, indicating whether it was the first time Hotjar saw this user.
_hjIncludedInPageviewSample2 minutesHotjar sets this cookie to know whether a user is included in the data sampling defined by the site's pageview limit.
_hjIncludedInSessionSample2 minutesHotjar sets this cookie to know whether a user is included in the data sampling defined by the site's daily session limit.
_hjSession_112884430 minutesHotjar sets this cookie.
_hjSessionUser_11288441 yearHotjar sets this cookie.
CONSENT2 yearsYouTube sets this cookie via embedded youtube-videos and registers anonymous statistical data.
Targeting
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
SAVE & ACCEPT
Powered by CookieYes Logo